Skip to Content

SANDOZ 625 (Rivastigmine Tartrate 6 mg)

Pill with imprint SANDOZ 625 is Orange / Red, Capsule-shape and has been identified as Rivastigmine Tartrate 6 mg. It is supplied by Sandoz Pharmaceuticals Inc..

Rivastigmine is used in the treatment of alzheimer's disease; parkinson's disease and belongs to the drug class cholinesterase inhibitors. There is no proven risk in humans during pregnancy. Rivastigmine 6 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for SANDOZ 625

Rivastigmine tartrate 6 mg SANDOZ 625
Rivastigmine tartrate 6 mg SANDOZ 625
Rivastigmine tartrate 6 mg SANDOZ 625

Rivastigmine Tartrate

Imprint:
SANDOZ 625
Strength:
6 mg
Color:
Orange / Red
Size:
18.00 mm
Shape:
Capsule-shape
Availability:
Prescription only
Drug Class:
Cholinesterase inhibitors
Pregnancy Category:
B - No proven risk in humans
CSA Schedule:
Not a controlled drug
Labeler / Supplier:
Sandoz Pharmaceuticals Inc.
National Drug Code (NDC):
00781-2617
Inactive Ingredients:

Note: Inactive ingredients may vary.

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide